Abstract
ETHIONAMIDE (2-ethyl-4-thiocarbamoylpyridine) (I) is a drug which has been introduced recently for the treatment of tuberculosis and which is undergoing widespread clinical trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kane, P. O., in Advances in Polarography, edit. by Longmuir, 3, 1076 (1959).
Libermann, D., French Patent No. 1105 M—Bull. Off. de la Prop. Indust., No. 10, March 5 (1962).
Kane, P. O., J. Electroanal. Chem., 2, 152 (1961).
Hughes, I. E., Smith, H., and Kane, P. O., Lancet, i, 616 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
KANE, P. Identification of a Metabolite of the Antituberculous Drug Ethionamide. Nature 195, 495–496 (1962). https://doi.org/10.1038/195495a0
Issue Date:
DOI: https://doi.org/10.1038/195495a0
This article is cited by
-
Vergleichende In-vitro-Untersuchungen zur tuberkulostatischen Wirksamkeit des Aethionamids und seines Sulfoxyds
Beiträge zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten (1965)
-
Zum Stoffwechsel des Äthioniamids
The Science of Nature (1964)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
